TLDRocket
Sign in

Drug Discovery

20 summarised stories about Drug Discovery, each linking back to the original source. Browse all topics →

Wednesday, 1 July 2026

🔬 The Coolest Diffusion Research Isn't in LLMs — Evan Feinberg & Sergey Edunov, Genesis Molecular AI

Latent Space 2 weeks ago

Genesis Molecular AI has developed PEARL, a diffusion-based model that predicts how drug molecules bind to proteins by accounting for protein flexibility and induced-fit dynamics that traditional methods cannot handle. The model achieved superior performance on the OpenBind benchmark of 802 unseen protein-ligand complexes, consistently reaching 1 Ångstrom RMSD accuracy—a threshold necessary for correctly modeling interactions like hydrogen bonds, compared to the field's inadequate 2 Ångstrom standard. This accuracy enables autonomous drug discovery agents to iterate through molecular design cycles continuously, combining computational predictions with automated lab testing to accelerate the search through 10^60 possible drug-like molecules.